“Protecting Innovation in a Borderless Pharma Economy: The Reality of Globalized Pharma Innovation”

As pharmaceutical innovation becomes increasingly globalized, companies face growing challenges in protecting intellectual property across jurisdictions, partnerships, and evolving regulatory frameworks. In an article published by Drug Discovery & Development, Marshall Gerstein Partner Shelley C. Danek, Ph.D., explores how pharmaceutical companies can navigate the realities of a borderless innovation economy while protecting valuable innovations and maintaining competitive advantages.

In her article, Shelley discusses the importance of coordinated international IP strategies, early planning, and understanding how differing patent and enforcement systems can impact commercialization efforts worldwide.

Read Shelley’s article in Drug Discovery & Development.